vs

Side-by-side financial comparison of Inogen Inc (INGN) and LIVEPERSON INC (LPSN). Click either name above to swap in a different company.

Inogen Inc is the larger business by last-quarter revenue ($68.6M vs $59.3M, roughly 1.2× LIVEPERSON INC). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -19.0%). Inogen Inc produced more free cash flow last quarter ($-1.9M vs $-12.0M). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -16.6%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

LivePerson is a global technology company that develops conversational commerce and AI software.

INGN vs LPSN — Head-to-Head

Bigger by revenue
INGN
INGN
1.2× larger
INGN
$68.6M
$59.3M
LPSN
Growing faster (revenue YoY)
INGN
INGN
+22.4% gap
INGN
3.4%
-19.0%
LPSN
More free cash flow
INGN
INGN
$10.0M more FCF
INGN
$-1.9M
$-12.0M
LPSN
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
-16.6%
LPSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
LPSN
LPSN
Revenue
$68.6M
$59.3M
Net Profit
$-46.1M
Gross Margin
51.4%
73.2%
Operating Margin
-13.6%
-68.7%
Net Margin
-77.8%
Revenue YoY
3.4%
-19.0%
Net Profit YoY
58.9%
EPS (diluted)
$-0.26
$-9.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
LPSN
LPSN
Q4 25
$68.6M
$59.3M
Q3 25
$79.1M
$60.2M
Q2 25
$79.2M
$59.6M
Q1 25
$68.5M
$64.7M
Q4 24
$66.3M
$73.2M
Q3 24
$74.9M
$74.2M
Q2 24
$74.4M
$79.9M
Q1 24
$63.1M
$85.1M
Net Profit
INGN
INGN
LPSN
LPSN
Q4 25
$-46.1M
Q3 25
$-5.3M
$8.7M
Q2 25
$-4.2M
$-15.7M
Q1 25
$-6.2M
$-14.1M
Q4 24
$-112.1M
Q3 24
$-6.0M
$-28.3M
Q2 24
$-5.6M
$41.8M
Q1 24
$-14.6M
$-35.6M
Gross Margin
INGN
INGN
LPSN
LPSN
Q4 25
51.4%
73.2%
Q3 25
52.2%
71.4%
Q2 25
52.2%
69.7%
Q1 25
53.1%
71.8%
Q4 24
54.7%
77.4%
Q3 24
55.2%
73.1%
Q2 24
57.4%
79.4%
Q1 24
54.5%
71.3%
Operating Margin
INGN
INGN
LPSN
LPSN
Q4 25
-13.6%
-68.7%
Q3 25
-9.0%
-24.2%
Q2 25
-7.7%
-10.8%
Q1 25
-11.2%
-26.2%
Q4 24
-17.2%
-138.0%
Q3 24
-10.4%
-21.6%
Q2 24
-9.5%
-37.3%
Q1 24
-25.8%
-42.7%
Net Margin
INGN
INGN
LPSN
LPSN
Q4 25
-77.8%
Q3 25
-6.7%
14.5%
Q2 25
-5.2%
-26.4%
Q1 25
-9.0%
-21.8%
Q4 24
-153.2%
Q3 24
-8.0%
-38.1%
Q2 24
-7.5%
52.3%
Q1 24
-23.1%
-41.8%
EPS (diluted)
INGN
INGN
LPSN
LPSN
Q4 25
$-0.26
$-9.22
Q3 25
$-0.20
$-2.76
Q2 25
$-0.15
$-0.17
Q1 25
$-0.25
$-0.24
Q4 24
$-0.41
$-17.23
Q3 24
$-0.25
$-4.74
Q2 24
$-0.24
$-0.33
Q1 24
$-0.62
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
LPSN
LPSN
Cash + ST InvestmentsLiquidity on hand
$103.7M
$95.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$192.2M
$-44.5M
Total Assets
$298.6M
$454.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
LPSN
LPSN
Q4 25
$103.7M
$95.0M
Q3 25
$106.5M
$106.7M
Q2 25
$103.7M
$162.0M
Q1 25
$118.9M
$176.3M
Q4 24
$113.8M
$183.2M
Q3 24
$105.7M
$142.1M
Q2 24
$97.9M
$146.0M
Q1 24
$107.4M
$127.1M
Total Debt
INGN
INGN
LPSN
LPSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$512.1M
Stockholders' Equity
INGN
INGN
LPSN
LPSN
Q4 25
$192.2M
$-44.5M
Q3 25
$197.2M
$-22.1M
Q2 25
$199.5M
$-82.4M
Q1 25
$198.0M
$-74.9M
Q4 24
$173.9M
$-67.3M
Q3 24
$185.4M
$45.9M
Q2 24
$187.6M
$66.6M
Q1 24
$191.9M
$19.2M
Total Assets
INGN
INGN
LPSN
LPSN
Q4 25
$298.6M
$454.7M
Q3 25
$307.0M
$511.4M
Q2 25
$312.0M
$604.2M
Q1 25
$308.4M
$596.2M
Q4 24
$296.2M
$607.8M
Q3 24
$306.2M
$692.0M
Q2 24
$308.9M
$703.8M
Q1 24
$315.6M
$724.7M
Debt / Equity
INGN
INGN
LPSN
LPSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
26.69×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
LPSN
LPSN
Operating Cash FlowLast quarter
$-943.0K
$-9.7M
Free Cash FlowOCF − Capex
$-1.9M
$-12.0M
FCF MarginFCF / Revenue
-2.8%
-20.2%
Capex IntensityCapex / Revenue
1.4%
3.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M
$-42.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
LPSN
LPSN
Q4 25
$-943.0K
$-9.7M
Q3 25
$2.2M
$-6.0M
Q2 25
$4.3M
$-11.7M
Q1 25
$-16.8M
$-3.1M
Q4 24
$-3.0M
$-3.1M
Q3 24
$7.0M
$4.8M
Q2 24
$6.7M
$-17.9M
Q1 24
$-4.7M
$1.1M
Free Cash Flow
INGN
INGN
LPSN
LPSN
Q4 25
$-1.9M
$-12.0M
Q3 25
$1.6M
$-8.9M
Q2 25
$3.7M
$-14.8M
Q1 25
$-17.1M
$-6.9M
Q4 24
$-3.3M
$-6.8M
Q3 24
$5.3M
$-230.0K
Q2 24
$6.6M
$-22.9M
Q1 24
$-6.1M
$-10.4M
FCF Margin
INGN
INGN
LPSN
LPSN
Q4 25
-2.8%
-20.2%
Q3 25
2.0%
-14.8%
Q2 25
4.6%
-24.9%
Q1 25
-24.9%
-10.6%
Q4 24
-5.0%
-9.2%
Q3 24
7.1%
-0.3%
Q2 24
8.9%
-28.7%
Q1 24
-9.6%
-12.2%
Capex Intensity
INGN
INGN
LPSN
LPSN
Q4 25
1.4%
3.9%
Q3 25
0.7%
4.8%
Q2 25
0.9%
5.3%
Q1 25
0.4%
5.8%
Q4 24
0.5%
5.0%
Q3 24
2.2%
6.8%
Q2 24
0.1%
6.2%
Q1 24
2.1%
13.5%
Cash Conversion
INGN
INGN
LPSN
LPSN
Q4 25
Q3 25
-0.69×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-0.43×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

LPSN
LPSN

Hosted Services Business$51.0M86%
Professional Services$8.3M14%

Related Comparisons